The dysregulation of monocyte subpopulations in individuals at risk of developing rheumatoid arthritis
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11510%2F21%3A10428540" target="_blank" >RIV/00216208:11510/21:10428540 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00023728:_____/21:N0000074 RIV/00216208:11110/21:10428540
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=GhIwFWUekE" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=GhIwFWUekE</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/rheumatology/keaa518" target="_blank" >10.1093/rheumatology/keaa518</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The dysregulation of monocyte subpopulations in individuals at risk of developing rheumatoid arthritis
Popis výsledku v původním jazyce
Objectives. Individuals carrying antibodies against citrullinated proteins (ACPA) are at high risk of developing RA. EULAR provided a clinical definition of individuals with arthralgia suspicious for progression to RA (clinically suspect arthralgia, CSA). The alteration of monocyte subpopulations in patients with established RA has been previously described. We analysed peripheral blood monocyte subpopulations in individuals with arthralgia at risk of RA. Methods. We included 70 at-risk individuals, defined as having arthralgia without arthritis and being either ACPA(+) or meeting the clinical CSA definition, 23 patients with early RA (ERA) and 19 healthy controls (HCs). Monocytes classified as classical (CD14(++)CD16(-)), intermediate (CD14(++)CD16(+/++)) and nonclassical (CD14(-/+)CD16(++)) were analysed by flow cytometry. Results. Of the 70 at-risk individuals, 46 were ACPA(+) and 45 met the CSA definition. The at-risk individuals and, especially, ERA patients had a lower percentage of classical monocytes and a higher percentage of nonclassical monocytes than the HCs. ACPA positivity had no effect on the difference in the distribution of the monocyte subsets between at-risk individuals and ERA patients, but a difference was determined in those reaching the ERA phase. However, when compared with HCs, the shift of monocyte subsets was more significant in ACPA(+) than in ACPA(-) individuals with arthralgia. This trend was observed in individuals who did not meet the CSA definition. This finding was, however, determined by a selection bias, as these individuals were solely ACPA(+). Conclusion. The shift from classical to nonclassical monocyte subpopulations was observed already in individuals at risk of developing RA.
Název v anglickém jazyce
The dysregulation of monocyte subpopulations in individuals at risk of developing rheumatoid arthritis
Popis výsledku anglicky
Objectives. Individuals carrying antibodies against citrullinated proteins (ACPA) are at high risk of developing RA. EULAR provided a clinical definition of individuals with arthralgia suspicious for progression to RA (clinically suspect arthralgia, CSA). The alteration of monocyte subpopulations in patients with established RA has been previously described. We analysed peripheral blood monocyte subpopulations in individuals with arthralgia at risk of RA. Methods. We included 70 at-risk individuals, defined as having arthralgia without arthritis and being either ACPA(+) or meeting the clinical CSA definition, 23 patients with early RA (ERA) and 19 healthy controls (HCs). Monocytes classified as classical (CD14(++)CD16(-)), intermediate (CD14(++)CD16(+/++)) and nonclassical (CD14(-/+)CD16(++)) were analysed by flow cytometry. Results. Of the 70 at-risk individuals, 46 were ACPA(+) and 45 met the CSA definition. The at-risk individuals and, especially, ERA patients had a lower percentage of classical monocytes and a higher percentage of nonclassical monocytes than the HCs. ACPA positivity had no effect on the difference in the distribution of the monocyte subsets between at-risk individuals and ERA patients, but a difference was determined in those reaching the ERA phase. However, when compared with HCs, the shift of monocyte subsets was more significant in ACPA(+) than in ACPA(-) individuals with arthralgia. This trend was observed in individuals who did not meet the CSA definition. This finding was, however, determined by a selection bias, as these individuals were solely ACPA(+). Conclusion. The shift from classical to nonclassical monocyte subpopulations was observed already in individuals at risk of developing RA.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30226 - Rheumatology
Návaznosti výsledku
Projekt
<a href="/cs/project/NV17-32612A" target="_blank" >NV17-32612A: Klinicky suspektní artralgie: charakteristika preklinické fáze revmatoidní artritidy</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Rheumatology
ISSN
1462-0324
e-ISSN
—
Svazek periodika
60
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
9
Strana od-do
1823-1831
Kód UT WoS článku
000644544400044
EID výsledku v databázi Scopus
2-s2.0-85104048166